Other broad EC markers included the angiogenesis-related EGFL7 (ref. 7); the Wnt inhibitor TMEM88, which regulates angioblast differentiation during development8; and c-type lectin CLEC14A, considered a potential target for tumour angiogenesis9 (Fig. 1c and Supplementary Data Fig. 4). The gene discussed is CLEC14A; the disease is neoplasm.